API | zotepine

zotepine Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Zotepine is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. It has been used in Germany since 1990 and Japan since 1982. ^Wikipedia

Chemistry

SMILES: CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13
InChIKey: HDOZVRUNCMBHFH-UHFFFAOYSA-N
Mol. Mass: 331.87
ALogP: 4.88 Partition coefficient
ChEMBL Molecule:
zotepine

More Chemistry

Pharmacology

Mechanisms of Action:
- D(1A) dopamine receptor (Homo sapiens) ^UniProt
- D(2) dopamine receptor (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (2)

Research & Development (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Schizophrenia

Experimental Indications - Clinical Trial Phases 1-4 (1)

Schizophrenia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 1
# of Trial Organizations: 2

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue